The Harvard Drug Group's Financial Acquisition

The Harvard Drug Group raised a round of funding on December 18, 2006. Investors include H.I.G. Ventures.

Harvard Drug is an independent generics-focused pharmaceutical distributor in the United States with nearly $500 million in annual sales. Harvard Drug supplies generic and branded pharmaceuticals to o…

Articles about The Harvard Drug Group's Financial Acquisition: